By Editor , 2 October 2026

Tianjin, China – October 02, 2026 -- Tianjin University's "Shengong-Shengao" system has become China's first approved brain-computer interface (BCI) medical device for diagnosing cognitive impairment, cutting diagnosis time for conditions like hydrocephalus from days to just 30 minutes. The milestone marks a commercial breakthrough as TJU, China's first modern university, marks its 131st anniversary on October 2, 2026.

By Editor , 2 October 2026
DOOR Ends Four-Year SEC Probe With $1 Million Settlement

St. Louis – October 01, 2026 -- DOOR (OTC: LTCH) has finalized a settlement with the U.S. Securities and Exchange Commission, closing a four-year investigation into legacy revenue recognition and key performance indicator practices with a $1.0 million civil penalty payable in quarterly installments.

SEC closes investigation that began in 2022

The SEC approved the previously disclosed settlement, which the Company first announced in principle on August 10, 2026. DOOR consented to an administrative order without admitting or denying the regulator's findings.

By Editor , 2 October 2026
Curaleaf's QMID Becomes First TGA-Registered Cannabis Inhaler in Australia

London – October 01, 2026 -- Curaleaf International's Que Medical Inhalation Device (QMID) has become the first cannabis inhalation device to secure registration from Australia's Therapeutic Goods Administration, clearing the way for clinicians to prescribe a standardized-dosing device in a market that has treated more than one million patients since 2016.

By Editor , 2 October 2026
SerpApi Earns ISO/IEC 27701 Privacy Certification

Austin, Texas – October 01, 2026 -- SerpApi, a provider of structured search data APIs, has achieved ISO/IEC 27701:2019 certification, an internationally recognized standard for Privacy Information Management Systems (PIMS).

By Editor , 2 October 2026
ANSI, America Makes Launch AM Standards Database, Gaps Report

New York – October 01, 2026 -- The American National Standards Institute (ANSI) and America Makes have launched a searchable online database of additive manufacturing (AM) standards alongside a September 2026 Gaps Progress Report, giving manufacturers and regulators a clearer map of which safety and performance standards exist, which are in development, and where coverage is still missing.

By Editor , 2 October 2026
Calamos Discloses October Distributions, Section 19(a) Notices for 7 Funds

Metro Chicago – October 01, 2026 -- Calamos Investments has declared monthly distributions paid in October 2026 across seven of its closed-end funds, accompanied by mandatory source-of-distribution disclosures required under Section 19 of the Investment Company Act of 1940.

By Editor , 1 October 2026
CMS Grants NTAP Status to Cerapedics' PearlMatrix Bone Graft

Westminster, Colo. – October 01, 2026 -- The Centers for Medicare & Medicaid Services has granted New Technology Add-On Payment status to Cerapedics Inc.'s PearlMatrix P-15 Peptide Enhanced Bone Graft, enabling hospitals to recoup up to 65% of the additional cost tied to the device starting October 1, 2026.

By Editor , 1 October 2026
Coretek Earns ISO/IEC 42001 AI Governance Certification

Farmington Hills – October 01, 2026 -- Coretek has achieved ISO/IEC 42001 certification, becoming among the first organizations globally to earn the world's first international standard for Artificial Intelligence Management Systems (AIMS).

By Editor , 1 October 2026
PG&E Files 10-Year Plan to Bury 5,000 Miles of Power Lines

Oakland, Calif. – October 01, 2026 -- Pacific Gas and Electric Company (PG&E) has filed a proposed 10-Year Electrical Undergrounding Plan (EUP) with the California Office of Energy Infrastructure Safety, projecting $117 billion in long-term benefits from burying 5,000 miles of distribution lines across more than 30 Northern and Central California counties between 2028 and 2037.

By Editor , 1 October 2026
HoneyNaps Gains CRO Status, Expands AI Sleep Data Services for Pharma

Boston – October 01, 2026 -- HoneyNaps, an AI-based sleep health technology company, has completed registration as a clinical research organization (CRO) with South Korea's National Enterprise for Clinical Trials (KoNECT), broadening its role in pharmaceutical and medical device trials worldwide.